Results 41 to 50 of about 631,998 (390)

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.

open access: yesNew England Journal of Medicine, 2019
Genome sequencing is often pivotal in the diagnosis of rare diseases, but many of these conditions lack specific treatments. We describe how molecular diagnosis of a rare, fatal neurodegenerative condition led to the rational design, testing, and ...
Jinkuk Kim   +52 more
semanticscholar   +1 more source

Phosphorothioate modified oligonucleotide–protein interactions

open access: yesNucleic Acids Research, 2020
Antisense oligonucleotides (ASOs) interact with target RNAs via hybridization to modulate gene expression through different mechanisms. ASO therapeutics are chemically modified and include phosphorothioate (PS) backbone modifications and different ribose
S. Crooke, T. Vickers, Xue-hai Liang
semanticscholar   +1 more source

Antisense oligonucleotides [PDF]

open access: yesNeurology Genetics, 2019
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine.
Eric Vallabh Minikel   +2 more
openaire   +3 more sources

Detection of minority variants within bovine respiratory syncytial virus populations using oligonucleotide-based microarrays [PDF]

open access: yes, 2008
Microarray technology, originally developed for highly parallel examination of gene expression is regarded as a potential tool in prognosis and diagnosis.
Baranowski, Eric   +4 more
core   +2 more sources

The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize

open access: yesMolecular Therapy: Nucleic Acids, 2022
mRNA is like Hermes, delivering the genetic code to cellular construction sites, so it has long been of interest, but only to a small group of scientists, and only demonstrating its remarkable efficacy in coronavirus disease 2019 (COVID-19) vaccines ...
Miroslaw Janowski, Anna Andrzejewska
doaj  

Synthesis of Unmodified Oligonucleotides [PDF]

open access: yesCurrent Protocols in Nucleic Acid Chemistry, 2002
Peer Reviewed ; https://deepblue.lib.umich.edu/bitstream/2027.42/152987/1/cpnc0300 ...
openaire   +5 more sources

Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancer

open access: yesMolecular Therapy: Nucleic Acids, 2023
Tumor suppressor genes (TSGs) are frequently downregulated in cancer, leading to dysregulation of the pathways that they control. The continuum model of tumor suppression suggests that even subtle changes in TSG expression, for example, driven by ...
Georgina L. Gregory, Ian M. Copple
doaj  

Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

open access: yesMolecules, 2017
Oligonucleotide (ON) drugs, including small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotides, are promising therapeutic agents.
Yating Sun   +5 more
doaj   +1 more source

Watching the hands of the Arabidopsis biological clock [PDF]

open access: yes, 2001
Oligonucleotide and cDNA microarrays have been used to analyse the mRNA levels of 8,000 genes in Arabidopsis thaliana throughout the day/night cycle. Genes involved in signal transduction and in various metabolic pathways were found to be coordinately ...
Davis, Seth J.   +1 more
core   +2 more sources

Rapid and accurate synthesis of TALE genes from synthetic oligonucleotides

open access: yesBioTechniques, 2016
Custom synthesis of transcription activator-like effector (TALE) genes has relied upon plasmid libraries of pre-fabricated TALE-repeat monomers or oligomers.
Fenghua Wang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy